University of Miami Cancer Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goldberg, John
KEYNOTE-B73, NCT04348916: Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors

Terminated
1
66
Canada, US
ONCR-177, pembrolizumab, MK-3475, KEYTRUDA
Oncorus, Inc., Merck Sharp & Dohme LLC
Cancer, Melanoma, Solid Tumor, Squamous Cell Carcinoma of Head and Neck, Breast Cancer, Advanced Solid Tumor, Triple Negative Breast Cancer, Colorectal Carcinoma, Non-melanoma Skin Cancer, Liver Metastases
05/23
05/23
Soff, Gerald
ACT-GI, NCT05772546: Avatrombopag Vs. Placebo for CIT in GI Malignancies

Recruiting
2
60
US
Avatrombopag, Doptelet, avatrombopag maleate, Matching Placebo
Hanny Al-Samkari, MD, Swedish Orphan Biovitrum
Gastrointestinal Cancer, Gastrointestinal Neoplasms, Chemotherapy-Induced Thrombocytopenia
03/25
07/25
NCT04673266: Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

Active, not recruiting
2
11
US
Romiplostim
Memorial Sloan Kettering Cancer Center, Amgen, Tel-Aviv Sourasky Medical Center
Lymphoma Patients, Thrombocytopenia
12/25
12/25
Lattanzi, Stephen
ACT-GI, NCT05772546: Avatrombopag Vs. Placebo for CIT in GI Malignancies

Recruiting
2
60
US
Avatrombopag, Doptelet, avatrombopag maleate, Matching Placebo
Hanny Al-Samkari, MD, Swedish Orphan Biovitrum
Gastrointestinal Cancer, Gastrointestinal Neoplasms, Chemotherapy-Induced Thrombocytopenia
03/25
07/25

Download Options